News Conference News VIVA 2023 New Carotid Stent Systems Associated With Low Stroke Risk L.A. McKeown November 09, 2023
News Conference News VIVA 2023 PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI L.A. McKeown November 01, 2023
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2021 Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms L.A. McKeown October 07, 2021
News Conference News VIVA 2021 Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis L.A. McKeown October 06, 2021
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020
News Conference News VIVA 2019 Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel L.A. McKeown November 08, 2019
News Conference News VIVA 2019 IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB L.A. McKeown November 05, 2019
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News VIVA 2018 Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention L.A. McKeown November 09, 2018
News Conference News VIVA 2018 IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions L.A. McKeown November 06, 2018